BioSig Technologies, Inc. (STEX)
NASDAQ · Financial Services
BioSig Technologies, Inc. Shareholder Equity 2020–2024
BioSig Technologies, Inc. annual/quarterly shareholder equity history from 2020 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- BioSig Technologies, Inc. shareholder equity for the quarter ending December 31, 2024 were -1.5M, a 48.84% decrease year-over-year.
- BioSig Technologies, Inc. shareholder equity for 2024 were -1.5M, a 48.84% decrease from 2023.
- BioSig Technologies, Inc. shareholder equity for 2023 were -3.0M, a 1064.22% decrease from 2022.
- BioSig Technologies, Inc. shareholder equity for 2022 were 313,000, a 97.44% decrease from 2021.
- BioSig Technologies, Inc. shareholder equity for 2021 were 12.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BioSig Technologies, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $-2 |
| 2023 | $-3 |
| 2022 | $0 |
| 2021 | $12 |
| 2020 | $24 |
| BioSig Technologies, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2024-12-31 | $-2 |
| 2023-12-31 | $-3 |
| 2022-12-31 | $0 |
| 2021-12-31 | $12 |
| 2020-12-31 | $24 |
BioSig Technologies, Inc. Shareholder Equity — FAQ
BioSig Technologies, Inc. (STEX) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STEX's shareholder equity history?
The chart and table above show BioSig Technologies, Inc.'s shareholder equity by year and by quarter, including the growth rate.